Showing posts with label meme. Show all posts
Showing posts with label meme. Show all posts

Friday, June 26, 2026

Chemical Imbalance Theory - Meme, Trope or Metaphor?

 


A while back I posted about how the “chemical imbalance theory” was a meme that originated in pharmaceutical advertising and all of the evidence to support that observation. This post is about whether that was really a trope and also why psychiatrists should not do too deep of a dive into the neurobiology of medications as a reaction. My concern about the deep dive came from something I saw on LinkedIn, that made the mistake of taking chemical imbalance quite literally rather than the rhetoric commonly used by the detractors of psychiatry.  The suggested strategy was outlining the known neurobiology of antidepressants – a strategy I do not favor.

First things first.  The difference between a meme and a trope has always seemed poorly delineated.  Richard Dawkins is credited with defining a meme as a unit of cultural transmission for evolutionary purposes.  Common modern usage is that it is an image, piece of text, or video that spreads rapidly on the internet and is adapted by various users.  A famous example is the Bernie Sanders mitten meme. A trope is a recurring theme or literary device used in storytelling that audiences immediately recognize.  It is a figure of speech.  In advertising the tropes may be less explicit.  Some examples include a white coat expert speaking authoritatively about a product, the suggestion that a product either directly or indirectly makes you more attractive or successful, or the suggestion that a product makes you more savvy or competent.

Here is a direct comparison between memes and tropes across key cultural and linguistic dimensions (1).




Considering all of the dimensions and definitions the chemical imbalance theory is possibly one of the most effective advertising tropes ever used.  At the time that the first SSRIs and SNRIs were approved by the FDA, all of the companies involved were focused on this trope.  From my original post - the chemical imbalance theory was also referred to when bupropion was marketed in the negative sense that it was “non-serotonergic” and had “minimal risk of sexual dysfunction”.  Some of the ads included a rough scorecard of receptor activity.  These medications were being marketed like potential customers were neurochemists and the mechanism of action of the medications were known.  As noted in the core definition in the above table, the figurative language of chemical imbalance is a shortcut to bypass a very complex process.

An additional consideration of an advertising trope is that it can also be turned into a meme and I think this occurred. In those pre-Internet days, early SSRI advertising overlapped with National Depression Screening Day.  Exposure of attendees and physicians at that screening was thorough and people in the community were being exposed to the same trope in TV and magazine ads.  It was not long before I started to encounter patients in the late 1990s that wanted to know if they had a chemical imbalance.

The academic literature at the time did not reflect the term and has not ever since.  The originators of the monoamine hypothesis of depression were much more circumspect – considering depression to be a complex multifactorial disorder that could not be explained by a simple change in monoamines. Since that era there have been over 100 hypotheses about depression with many carried forward to current times.  The serotonin based theories of depression have faded rapidly over the past 2 decades even though serotonergic systems are important for brain function and sophisticated in vivo monitoring has shown that antidepressants of several classes all increase extraneuronal serotonin levels.  As noted in the above link, Charney and Nestler’s text currently aggregates depression hypotheses under neurotrophic, immune, and neuroendocrine headings.  The specifics at this point are lacking and since depression is a heterogenous condition with multiple known medical and substance induced etiologies it will take subtypes that are clearly defined by more than written criteria.  At some point I hope to provide a more detailed map, but for now I will get back to the trope rather than the science.

The detractors of psychiatry can always be counted upon to throw a trope at the wall and see what sticks.  What better trope to use than a wildly successful one from Pharma marketing?  Just add that psychiatrists are intellectually dishonest and are just selling pharmaceuticals like drug companies and pretending to know the cause of depression and the mechanism of action of antidepressants. You might even extend that rhetoric to suggest that psychiatrists need to cling to that certainty in order to legitimize themselves in medicine.

Is any of that rhetoric legitimate? First, all FDA approved package inserts have a Mechanism of Action section.  For many medications that section has a complete or provisional statement about the mechanism of action being unknown (14-18).  In the case of antidepressants, the mechanism of action is generally listed as involving monoaminergic transporters or receptors at some level.  Second, in reviews of drug targets in general antidepressant and antipsychotic medications are listed with respective targets like most other medications in clinical use (19).  Third, and most importantly – there is a tendency to think of rhetoric, memes, tropes, and metaphor as being limited to arts and literature.  Cognitive scientists and linguists view these dimensions as the foundational mechanics of human communication and there is ample evidence that they are used in every discipline – including medicine and science.

At least part of the issue is that tropes, memes, and metaphors are not really part of the mainstream of medical or scientific literature. Nothing will be found in neurology, psychiatry, or even neuroscience texts.  It is generally covered by linguists or researchers who identify as both linguists and cognitive psychologists. That literature is useful to read because of the overlap with cognitive psychology and also how these foundational mechanics of language are used on a daily basis.  It provides an additional dimension for analysis of the literature in your primary field. It goes beyond language disorders and aphasias noted in medical practice.

The following table is a compilation of the current theories of metaphor – since that is the basis for many (but not all) tropes.  It shows how metaphors are theoretically more or less efficient and the main mechanism of action.  Interestingly the suggested mechanisms are basically processing metaphors.  In reading about modern theories of metaphors, it is clear that the landscape has changed to one that sees much human communication as being dependent on metaphors and the line between literal and figurative language as being much less clear.  Beyond that metaphors are seen as foundational cognitive mechanisms rather than just linguistic or literary devices.


In Conceptual Metaphor Theory (CMT) the mapping is a simplified or mechanistic view of the brain is mapped onto a complex (multifactorial/multidimensional) emotional state.  Once that is established the result is reasoning from that state suggests that correcting the imbalance with correct the associated stated. The cognitive load is decreased because thinking about all of the real neuroanatomy and neurophysiology is not necessary.  The reasoning is more like keeping your car full of gas or oil to keep it running.

Categorization Theory (CT) states that two unlike categories are not mapped but instead a new superordinate category is created.  The example in this case would be the category of things with mechanical or material deficiencies. This category includes things that are depleted and in need of repair like broken automobiles or vitamin deficiencies.  The brain and the car both do not work because of a material deficiency and once that is identified they can be repaired.

Career of Metaphor Theory (COMT) says that metaphors shift over time as they become more familiar.  They start out as active comparisons as suggested in the first two theories but eventually become their own categorizations as dead metaphors.  A dead metaphor no longer requires the active comparison. For example, early in the course chemical imbalance could be compared with another deficiency diseases like diabetes, but as time goes on and it is more accepted chemical imbalance is accepted as equivalent to depression without any imagination of the chemistry involved.

Deliberate Metaphor Theory (DMT) draws a distinction between metaphors that are used unconsciously and those that are introduced deliberately. The intentional metaphors are more often used rhetorically.  In this case, chemical imbalance was used intentionally as a marketing device to explain or legitimize the use of antidepressants.  It also shifts explanatory power away from environmental or psychological causes to biological ones.

As I read about these theories, I recalled the first time I was confronted with the chemical imbalance theory back in the 1980s.  It was presented to me by two pharmaceutical representatives.  As a guy with considerable biochemistry and chemistry experience my reaction was: “It sounds like you are saying the brain is just a bag of chemicals.”  They were not very happy with me.  But this approach and the theory did not have any traction with me.  There is concern within the science community about the use of metaphor and the possible inadequacies.  With chemical imbalance theory there are several including: it does not adequately describe the level of complexity involved, it does not accurately reflect the scientific literature, it creates a level of certainty that does not exist, and it has led to a trope where it is accepted at a political rather than a scientific level.

For all of these reasons, no psychiatrist should be using this trope clinically.  In the general population it is pervasive to the point that I have talked with patients who tell me how they are trying to correct their chemical imbalance.  The people I am referring to have never seen a psychiatrist and are trying to correct that imbalance by using street drugs.  They often have an elaborate scheme about how they can selectively increase various neurotransmitters to get certain effects. They were shocked when I advised them that things don’t work that way.

Returning to the reason for this post, what is necessary to say to most people for adequate and ethical informed consent?  I have reviewed this in several posts on this blog (20-26). Informed consent about both the diagnosis and treatment intervention is critical and it needs to be adapted for the abilities and preferences of every patient.  When I saw the reaction to the problems of the chemical imbalance trope being countered by the suggestion that psychiatrist present more detailed neurobiological information – I thought it reflected a lack of understanding of clinical reality and here is why:

1:  It does not reflect what most people want.  People come in to see psychiatrists at the last possible moment. The people I saw over the course of my career had already seen primary care physicians and therapists.  They were seeing me because nothing has worked.  In some cases, they had specific concerns about treatments or medications and wanted those concerns addressed initially.  That is often the easiest unasked question.

2:  Discussing alternate treatments and a no treatment option.  In the process I clarify my role as providing the best possible advice based on current science.

3:  In the case of medications – discussing my experience with the recommended medication including time course of response, typical side effects, rare but serious side effects, and indications to call me.  I also included a statement that most people wait too long to call or decide that they might “get used to” a side effect but that I prefer they call me about it.  

4:  A discussion of the therapeutic alliance, how that works, and the informed consent aspects.  This is often referred to as “shared decision-making” these days.  I will always prefer the models of therapeutic alliance and informed consent as a better fit for psychiatric practice.

5:  A discussion of other metaphors and tropes.  There are many more out there today due to the internet and popular science sites promoting them.  Just a few examples – “rewiring your brain”, “neuroplasticity”, “cleaning/cleansing your brain”, “reprogramming your brain”, brain as a "switchboard", brain regions as an "orchestra", need for brain "reset", brain as "hardware" and mind as "software", etc.  They are often used as a reason for diet, exercise, branded psychotherapies, self help, even a walk in the outdoors.  As far as I know none are used rhetorically and repeatedly by antipsychiatry despite the fact that many of the claims overblown.

Effective treatment should be what the informed consent decision is based on and that does not require that everyone become a neuroscientist any more than receiving dental care requires everyone to become an expert in teeth.       

This post has been an interesting excursion into linguistics, cognitive psychology, and rhetoric.  I discovered an entire field of metaphorical linguistics that I was unaware of.  Metaphor and simile are concepts right out of freshman English composition – but the idea that metaphor is a cognitive process is much more current.  The progression of metaphors over time is consistent with the conversion of episodic memory into semantic memory.  I have not been able to confirm whether any of the metaphor theorists believe that at this point or whether it has been written down anywhere.  I do encourage caution in using metaphors in psychiatry and agree with Kendler’s thesis that we do not need to avoid biological reality in discussions with patients. At the same time Kendler saw the need for metaphorical brain talk as arising out of the need for a brain focus combined with an explanatory gap, status anxiety over a clear underlying pathology, and a wish that we may eventually get to the deeper understanding of the brain that we all seek.  This missing piece is from linguistic theory that metaphor is a basic cognitive mechanism that we all use and the evidence is all of the depression tropes well beyond chemical imbalance at this point.     

In conclusion, meme, trope or metaphor - chemical imbalance has utility from a linguistic perspective and that may be why it persists at a rhetorical level today.  There is also overlap with the goals of that rhetoric as pejorative and I would argue it has attained dead metaphor status in that regard and therefore is not a term any psychiatrist should use.  

George Dawson, MD, DFAPA

 

Supplementary 1:

If you are a cognitive psychologist or linguist - I am interested in references that you would consider state of the art about the role of metaphor in cognition.

Supplementary 2:

This post reminded me that as a senior psychiatry resident, I was fortunate enough to have an office down the hall from two excellent speech and language pathologists. We had many great discussions about language, speech, and cognition.  That happened at the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin.

References:

1:  Animétudes.  Postmodern Media : Memes and Database Consumption.  May 3, 2020:  https://animetudes.com/2020/05/03/postmodern-media-memes-and-database-consumption/

2:  Kole M. Science fiction tropes: a guide for writers.  Good Story Company.  October 2019:  https://www.goodstorycompany.com/science-fiction-tropes

3:  Everywriter R.  100 science fiction tropes. Everywriter May4, 2024:  https://www.everywritersresource.com/100-science-fiction-tropes/

4:  TV Tropes.  Science fiction:  https://tvtropes.org/pmwiki/pmwiki.php/Main/ScienceFiction

5:  Taylor C, Dewsbury BM. On the problem and promise of metaphor use in science and science communication. Journal of microbiology & biology education. 2018 Mar;19(1):10-128.

6:  Bradie M. Science and metaphor. Biology and Philosophy. 1999 Apr;14(2):159-66.

7:  Reynolds AS. Understanding metaphors in the life sciences. Cambridge University Press; 2022 Apr 28.

8:  Mahootian F. Metaphor in chemistry: An examination of chemical metaphor. In: Philosophy of Chemistry: Growth of a New Discipline 2014 Oct 19 (pp. 121-139). Dordrecht: Springer Netherlands.

9:  Muller CH, Rau MA. Instructional analogies dominate, domain-inherent metaphors are overlooked: A systematic review of metaphorical mappings in chemistry education. Journal of Chemical Education. 2025 Jun 6;102(7):2576-91.

10:  Rodriguez X, Arroyo-Santos A. The function of scientific metaphors: An example of the creative power of metaphors in biological theories. InThe paths of creation. Creativity in science and art 2011 Jan (Vol. 9, pp. 81-96). Peter Lang Publishing Group Bern.

11:  Swiatczak B. Understanding life through metaphors: Andrew S. Reynolds: Understanding metaphors in the life sciences. Cambridge: Cambridge University Press, 2022, xx+ 200 pp,£ 11.99 PB.

12:  Veit W, Ney M. Metaphors in arts and science. European Journal for Philosophy of Science. 2021 Jun;11(2):44.

CT doesn’t mean all metaphors in science are legitimate. Just like some metaphors in artistic works are bad in various ways – bland, tasteless, confusing,etc. – some in science might be bad. Neither does it imply that the same criteria need to be used in evaluating metaphors in science as in the arts.

13:  Fernyhough C.  Metaphors of the mind.  British Psychological Society.  The Psychologist.  June 18, 2006:  https://www.bps.org.uk/psychologist/metaphors-mind

14:  FDA Package Insert: nortriptyline.

The mechanism of mood elevation by tricyclic antidepressants is at present unknown. Pamelor is not a monoamine oxidase inhibitor. It inhibits the activity of such diverse agents as histamine, 5-hydroxytryptamine, and acetylcholine. It increases the pressor effect of norepinephrine but blocks the pressor response of phenethylamine. Studies suggest that Pamelor interferes with the transport, release, and storage of catecholamines.

15:  FDA Package Insert: fluoxetine.

Although the exact mechanism of PROZAC is unknown, it is presumed to be linked to its inhibition of CNS neuronal uptake of serotonin.

16:  FDA Package Insert: venlafaxine.

The exact mechanism of the antidepressant action of venlafaxine in humans is unknown, but is thought to be related to the potentiation of serotonin and norepinephrine in the central nervous system, through inhibition of their reuptake. Non- clinical studies have demonstrated that venlafaxine and its active metabolite, ODV, are potent and selective inhibitors of neuronal serotonin and norepinephrine reuptake and weak inhibitors of dopamine reuptake.

17:  FDA Package Insert: bupropion.

The exact mechanism of the antidepressant action of bupropion is not known, but is presumed to be related to noradrenergic and/or dopaminergic mechanisms. Bupropion is a relatively weak inhibitor of the neuronal reuptake of norepinephrine and dopamine, and does not inhibit the reuptake of serotonin. Bupropion does not inhibit monoamine oxidase.

18:  FDA Package Insert: vortioxetine.

The mechanism of the antidepressant effect of vortioxetine is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS through inhibition of the reuptake of serotonin (5-HT). It also has several other activities including 5-HT3 receptor antagonism and 5-HT1A receptor agonism. The contribution of these activities to vortioxetine’s antidepressant effect has not been established.

19:  Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG, Karlsson A, Al-Lazikani B, Hersey A, Oprea TI, Overington JP. A comprehensive map of molecular drug targets. Nat Rev Drug Discov. 2017 Jan;16(1):19-34. doi: 10.1038/nrd.2016.230. Epub 2016 Dec 2. PMID: 27910877; PMCID: PMC6314433.

20:  The Spectrum of Caring About Medication Information:  https://real-psychiatry.blogspot.com/2014/05/the-spectrum-of-caring-about-medication.html

21:  Vigilance Is Required for Adequate Informed Consent:  https://real-psychiatry.blogspot.com/2019/04/vigilance-is-required-for-adequate.html

22:  The New Black Box Warning on Benzodiazepines:  https://real-psychiatry.blogspot.com/2021/03/the-new-black-box-warnings-on.html

23:  The Problem of Antidepressant Discontinuation:  https://real-psychiatry.blogspot.com/2018/06/the-problem-of-antidepressant.html

24:  2000 Words About the Last Ten Minutes of a Psychiatric Evaluation:  https://real-psychiatry.blogspot.com/2019/07/2000-words-about-last-ten-minutes-of.html

25:  Therapeutic Alliance - A Better Diagram:  https://real-psychiatry.blogspot.com/2017/09/therapeutic-alliance-better-diagram.html

26:  Components of Patient Outcome:  https://real-psychiatry.blogspot.com/2018/10/components-of-patient-outcome.html


Saturday, May 25, 2019

Chemical Imbalance As Advertising Meme




After a protracted discussion on the previous post, I thought I would go down to the University of Minnesota Biomed library today and look at the drug ads in psychiatric journals at about the time Prozac came out in 1987. I was interested in the trends before and after so I picked the years 1985 to 1995. I also picked the journals the American Journal of Psychiatry, Archives of General Psychiatry (currently JAMA Psychiatry), and the Journal of Clinical Psychiatry.  I was going to include JAMA and the New England Journal of Medicine.  They had about the same number of ads but none of them in that year contained ads for psychiatric medications.

This kind of search is labor intensive these days. There was a time on the early days of the Internet when entire journals with all of the ads were scanned in. As a subscriber I could have run that search from home.  These days, all of the ads are gone and the references are saved as text files only. In order to see historical ads - the hard copy of the original journal needs to be examined. Even then there are some problems.  I encountered some bound volumes where the ads were physically removed. There were two to three bound volumes per year and additional copies of the NEJM and JAMA - I may have looked at 75 bound volumes over 4 hours.

In many ways it was a walk down memory lane.  Clozaril and Haldol Decanoate ads were especially heavy in the early 1990s.  There were ads for medications that I prescribed all of the time like Navane and Pamelor and ads for drugs that I seldom prescribed like Stelazine, Serzone and Luvox. There were ads for new drugs that I would prescribe once like Paxil.  It was a reminder that despite all of the advertising - a  lot of drugs end up never being prescribed by physicians.  My reason for being there was to look for the origins of the term "chemical imbalance" in this advertising.

I decided to embark on this project because of all of the inaccuracy about the term, especially the tendency to blame psychiatrists for it. In my previous post, I attempted to point out that it is a fairly straightforward process to conclude that the human brain does not run on chemical imbalances - just based on the average scientific knowledge of physicians. On the advertising side, I was there for the first National Depression Screening Day in 1990 and that was the first time I heard the term. The event has been criticized as a venue for allowing a pharmaceutical company to showcase their product.  I participated in the event for 3 years and the advertising involved was much more subtle than is found today at NAMI walks for example. But the question is whether the advertising meme "chemical imbalance" was introduced at that time. Any event that happened 30 years ago is very hard to track. As the Public Affairs Rep for my District Branch of the APA, I had a lot of files about it that I subsequently trashed. I am guessing there were also some files on disk drives that would have been helpful.  This is a reconstruction without that data.

I successfully located the first Prozac ad in AJP from 1988.  The graphics are all iPhone photos so there is some distortion.  Chemistry is emphasized on page one as in the chemical structure, chemically unrelated to other antidepressants, distinctive chemistry, and the first highly specific and highly potent blocker of serotonin reuptake.



Why is this important? At the time most of the antidepressants being used were tricyclic antidepressants.  They could not claim any specificity and in subsequent ads manufacturers start to compare possible side effects based on transporter monoamine protein and receptor affinities. The Prozac molecule was being hyped as being chemically unique and with a better side effect profile. As Prozac started to sell more it became a blockbuster drug for Eli Lilly and at that point the manufacturers of other new antidepressants noted and the competition heated up.  There were some direct references to Prozac in the ads from competitors.

The best example is this Wellbutrin ad from AJP in 1991. Prozac is directly mentioned in the ad and reasons are given for choosing Wellbutrin over Prozac.  Being non-serotonergic is one of them and this is more of a counter to Prozac advertising as being a unique first highly selective serotonergic drug.  It gives little or no weight gain as a reason, but at the time I was seeing obese patients who were taking 80 mg of Prozac because their primary care physicians told them they could lose weight taking it. Of the other bullet points it seems that lack of sexual dysfunction would be  the most relevant. The marketing decision in this case was a conscious decision to go after the purported serotonergic effects of Prozac rather discuss the hypothetical mechanism of Wellbutrin.  The side effect of Wellbutrin that most physicians are concerned about - seizures - is in the smaller print below the bullet points.


Effexor came up with similar ads.  In the late 1980s and early 1990s, synaptosome technology was invented to look at binding affinities of central nervous system medications to specific receptor sites.  The quantitative aspects of these studies were generally globalized in the psychiatric literature to qualitative ballpark effects.  For example a plus or minus grading system could be used ranging from no effect at a receptor (-) to a robust effect (++++).  Effexor advertising used this to compare side effect profiles among the competitive antidepressants at the time.


This ad emphasizes that Effexor is "a structurally novel antidepressant and is chemically unrelated to any other available antidepressant."  It shows the table with comparisons to tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) and what might be predicted based on the in vitro synaptosome data with the qualifier that the clinical significance of that data is unknown.  Clinically most people are able to tolerate all three classes of medication but some will not.  The differences can't be predicted on the basis of the receptor binding studies because of receptor heterogeneity and differences in drug metabolism.  For example, I still prescribe TCAs. It is nortriptyline and it is the only one I have ever prescribed. At the doses I prescribe and per the table in the ad - it is as well tolerated as SSRIs and SNRIs (Effexor).  The ad appeared in the AJP in April of 1994.  On that basis the argument could be made that it is an appeal to the technical expertise of psychiatrists and it should contain this information.  That also points to a weakness in my informal advertising study and that is a lack of ads from the non-technical consumer literature from the same period. (see supplementary on a proposal).

I have 30 additional ads from the journals but the themes are roughly the same. An emphasis on medicinal chemistry and the suggestions that some chemistry is better than others. Interestingly, in my previous post the whole point was that this is the kind of argument that would not fly based on what the average physician knows about chemistry and molecular biology. Psychiatrists should know a lot more because the evidence for and against these theories had been reviewed in the psychiatric literature 20 years before these ads came out (1974-2002) (1).  And they are engaged in clinical practice and need to be skeptical of newly introduced products and claims.

What I did find so far is unequivocal evidence that the chemical imbalance meme was used to directly market antidepressants to the public.  The Zoloft ad embedded at the top of this page from 2001 is the first example.  The second example is this Paxil ad from the same year.

That is what I have so far.  See the Supplementary below to find out what you can do to complete the story. I don't have a problem with people telling me that their doctor told them that they have a chemical imbalance and their antidepressant is supposed to treat that. I don't have a problem with people saying that their psychiatrist told them that.  I do have a problem with people saying that all or even most psychiatrists say this and that psychiatrists are behind this meme.

There is an exaggerated focus on the mechanism of action of medications used for psychiatric indications. I have never heard anyone say their doctor told them about the mechanism of action of antibiotics or even their blood pressure medications. In the case of antibiotics it is clear that people demand them and they don't care what the risks or mechanisms are.  This advertising campaign may have something to do with the conversion of folk psychologists to folk psychopharmacologists.  A friend of mine also brought up an important aspect of this campaign that is also addressed by these manufacturers and that is legitimacy. For decades people with depression and anxiety were viewed as weak people with a questionable problem.  My friend told me that these ads confirmed that she had a serious problem that needed a serious solution and that it was finally acceptable to talk about it.  Say whatever you want about Big Pharma advertising but it apparently carried the message that current "Let's Talk About Mental Health" programs do - but over 15 years ago.

The attribution of an advertising meme to psychiatry and psychiatrists despite the fact it has never appeared in 30 years of psychopharmacology texts is not a trivial fact.  The advertising videos posted here  were viewed by tens of millions of people.  I hope to get more information and still have some people to contact. With any luck I will be able to fill in the additional data between the release date of Prozac in 1987 and the ads posted here from 2001.

Please send me anything you might have from those dates.



George Dawson, MD, DFAPA


References:

1.  Nathan KI, Schatzberg AF. Mood disorders. in Review of Psychiatry, vol 13. American Psychiatric Press, Washington DC(1994): p.171-184


Supplementary 1:

From the  information I posted above it is clear that chemical imbalance was an advertising meme introduced during the height of competition of blockbuster  antidepressant drugs.  The  common Wall Street definition of a blockbuster pharmaceutical is a product that generates sales of a billion dollars a year.  There are two important pieces of data that would be useful to complete the story.

The first is earlier ads with the term chemical imbalance. So far, I have two from 2001, but I am certain it appeared before that. I don't have time to search all of the popular literature.  If you subscribe to a magazine that has pharmaceutical advertising and keep all of the old volumes - take a look at the editions from about 1987 to 1995. If you see the term chemical imbalance please send me the image with the name and date of the periodical.  Let me know if you want credit for finding the image and I will give you full credit.

If you are a current or former pharmaceutical rep or marketing person and have access to any documents or videos with the chemical imbalance phrase please send it to me with the date it was being used. If you have recollections of how it was implemented and when I can also use that information but I am most interested in clear documentation like the videos I have posted. I have no interest in vilifying the pharmaceutical industry and understand the need for marketing and advertising.  I am just interested in the origins of this term and how it was implemented.

If you are an APA member and you were involved in the original National Depression Screening Day in 1990 - you may also have some information about this.  Please send it to me.

Thanks!


Supplementary 2:

All of the name brand drugs/medications mentioned in this post are currently generics or are no longer manufactured.  I have no affiliation with the original manufacturers or the generic drug industry.


Supplementary 3:

There are various Internet sites that attribute the term chemical imbalance to Pfizer or Lilly but they do not appear to be reliable - many appear to be antipsychiatry sites.  I would like to hear from people who were there at the time and can provide the necessary proof.  In those days (1986-1996) it would have been an internal memo or presentation.  Send me a copy if you have it.


Supplementary 4:

I had the opportunity to discuss this issue with a corporate attorney - especially the issue of available emails and memoranda dating back to 1987.  He told me that corporations hold this data only as long as the law states they needs to.  For example, if the law states the data must be held for 4 years it will be held exactly that long and then everything will be shredded.  If this information exists it will probably be in private hands.

Supplementary 5:

I got the expected low level feedback from a Twitter poster who thought he was making some point about this link on the Royal College of Psychiatrists web site suggesting that at least one of the causes of schizoaffective disorder was "a chemical imbalance".  I guess he really thought he had made me look foolish especially with the proclamation "You aren't psychiatry - they are."

https://www.rcpsych.ac.uk/mental-health/problems-disorders/schizoaffective-disorder

In fact, I can't tell who wrote this and whether or not it is a psychiatrist. I don't know what the RCP official position is.  I was happy to see that they are much more flexible than the anti-psychiatry Twitter posters I encounter.  There was a feedback form that I completed and advised them to lose the "chemical imbalance" and that replacing it with "unknown etiology" was preferable. What I would like to see is an exposition of the latest theories and a suggestion that the critics actually read psychiatric literature.  They would be less likely to perseverate the same criticism they have used for year after year. This poster also seemed to ignore the fact that the RCP public information was posted in 2015 - that's 14 years after the television ad posted at the top of this page.  Royal College of Psychiatrists - the ball is in your court.

Supplementary 6: (added on 1/11/2020):  I just learned today from an advertising expert in antidepressants that there was also a Zoloft ad from 2004 that used the term: 

"While the cause is unknown, Zoloft can help.  It works to correct a chemical imbalance in the brain that may be related to these symptoms."


Reference:

Cristina Hanganu-Bresch. Treat Her with Prozac: Four Decades of Direct-to-Physician Antidepressant Advertising in Drugs Media: New Perspectives on Communication, Consumption, and Consciousness (Hardback) (1st Edition) by Robert C. Macdougall (Editor), Drugs &. Media-Pasta Dura, 340 Pages, Published 2011 ISBN-10: 1-4411-1988-4 / 1441119884 ISBN-13: 978-1-4411-1988-9 / 9781441119889: